<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38534005</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1437-4331</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>Clinical chemistry and laboratory medicine</Title><ISOAbbreviation>Clin Chem Lab Med</ISOAbbreviation></Journal><ArticleTitle>The EFLM European Urinalysis Guideline 2023.</ArticleTitle><Pagination><StartPage>1653</StartPage><EndPage>1786</EndPage><MedlinePgn>1653-1786</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1515/cclm-2024-0070</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The EFLM Task and Finish Group Urinalysis has updated the ECLM European Urinalysis Guidelines (2000) on urinalysis and urine bacterial culture, to improve accuracy of these examinations in European clinical laboratories, and to support diagnostic industry to develop new technologies.</AbstractText><AbstractText Label="RECOMMENDATIONS" NlmCategory="CONCLUSIONS">Graded recommendations were built in the following areas.</AbstractText><AbstractText Label="MEDICAL NEEDS AND TEST REQUISITION" NlmCategory="UNASSIGNED">Strategies of urine testing are described to patients with complicated or uncomplicated urinary tract infection (UTI), and high or low-risk to kidney disease.</AbstractText><AbstractText Label="SPECIMEN COLLECTION" NlmCategory="UNASSIGNED">Patient preparation, and urine collection are supported with two quality indicators: contamination rate (cultures), and density of urine (chemistry, particles).</AbstractText><AbstractText Label="CHEMISTRY" NlmCategory="UNASSIGNED">Measurements of both urine albumin and &#x3b1;1-microglobulin are recommended for sensitive detection of kidney disease in high-risk patients. Performance specifications are given for urine protein measurements and quality control of multiproperty strip tests.</AbstractText><AbstractText Label="PARTICLES" NlmCategory="UNASSIGNED">Procedures for microscopy are reviewed for diagnostic urine particles, including urine bacteria. Technologies in automated particle counting and visual microscopy are updated with advice how to verify new instruments with the reference microscopy.</AbstractText><AbstractText Label="BACTERIOLOGY" NlmCategory="UNASSIGNED">Chromogenic agar is recommended as primary medium in urine cultures. Limits of significant growth are reviewed, with an optimised workflow for routine specimens, using leukocyturia to reduce less important antimicrobial susceptibility testing. Automation in bacteriology is encouraged to shorten turn-around times. Matrix assisted laser desorption ionization time-of-flight mass spectrometry is applicable for rapid identification of uropathogens. <i>Aerococcus urinae, A. sanguinicola</i> and <i>Actinotignum schaalii</i> are taken into the list of uropathogens. A reference examination procedure was developed for urine bacterial cultures.</AbstractText><CopyrightInformation>&#xa9; 2024 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kouri</LastName><ForeName>Timo T</ForeName><Initials>TT</Initials><Identifier Source="ORCID">0000-0002-3282-232X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HUSLAB, HUS Diagnostic Center, Hospital District of Helsinki and Uusimaa, 00014 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofmann</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Synlab MVZ, Augsburg and Dachau, 85221 Dachau, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falbo</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9797-1070</Identifier><AffiliationInfo><Affiliation>University Department of Laboratory Medicine, ASST Brianza, Pio XI Hospital, 20832 Desio (MB), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oyaert</LastName><ForeName>Matthijs</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0240-0679</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University Hospital Ghent, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schubert</LastName><ForeName>S&#xf6;ren</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5687-8977</Identifier><AffiliationInfo><Affiliation>Max von Pettenkofer Institute of Hygiene and Medical Microbiology, Faculty of Medicine, LMU Munich, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gertsen</LastName><ForeName>Jan Berg</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0001-8103-6790</Identifier><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Aarhus University Hospital, Skejby, 8200 Aarhus N, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merens</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de Biologie M&#xe9;dicale, H&#xf4;pital d'Instruction des Arm&#xe9;es B&#xe9;gin, 94160 Saint-Mand&#xe9;, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pestel-Caron</LastName><ForeName>Martine</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9888-7601</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, CHU Rouen, University of Rouen Normandie, INSERM, DYNAMICURE UMR 1311, 76000 Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Task and Finish Group for Urinalysis (TFG-U), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Chem Lab Med</MedlineTA><NlmUniqueID>9806306</NlmUniqueID><ISSNLinking>1434-6621</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016482" MajorTopicYN="Y">Urinalysis</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="N">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011786" MajorTopicYN="N">Quality Control</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bacteriological techniques</Keyword><Keyword MajorTopicYN="N">kidney diseases</Keyword><Keyword MajorTopicYN="N">practice guideline</Keyword><Keyword MajorTopicYN="N">reference measurement procedures</Keyword><Keyword MajorTopicYN="N">urinalysis</Keyword><Keyword MajorTopicYN="N">urinary tract infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>29</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>8</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38534005</ArticleId><ArticleId IdType="doi">10.1515/cclm-2024-0070</ArticleId><ArticleId IdType="pii">cclm-2024-0070</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>